[{"id":"1eccb30a-8ad1-4c26-a948-9dcc1f4fa1f2","acronym":"","url":"https://clinicaltrials.gov/study/NCT03832855","created_at":"2021-01-18T18:55:29.583Z","updated_at":"2025-02-25T12:27:07.330Z","phase":"Phase 1","brief_title":"Assessing the Immunogenicity of pING-hHER3FL","source_id_and_acronym":"NCT03832855","lead_sponsor":"Herbert Lyerly","biomarkers":" ERBB3","pipe":" | ","alterations":" ERBB3 expression","tags":["ERBB3"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e ERBB3 expression"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e pING-hHER3FL"],"overall_status":"Recruiting","enrollment":" Enrollment 24","initiation":"Initiation: 07/13/2020","start_date":" 07/13/2020","primary_txt":" Primary completion: 08/01/2025","primary_completion_date":" 08/01/2025","study_txt":" Completion: 08/01/2026","study_completion_date":" 08/01/2026","last_update_posted":"2025-02-24"}]